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To establish a practical research tool for studying the pathogenesis of retinal 
ganglion cell (RGC) diseases, we optimized culture procedures to induce neurite 
outgrowth from three-dimensional self-organizing optic vesicles (3D-retinas) 
differentiated in vitro from mouse and human embryonic stem cells (ESCs).  
Materials and methods 
 The developing 3D-retinas isolated at various time points were placed on Matrigel-
coated plates and cultured in media on the basis of the 3D-retinal culture or the 
retinal organotypic culture protocol. The number, length, and morphology of the 
neurites in each culture condition were compared. 
Results 
 First, we confirmed that Venus-positive cells were double-labeled with a RGC 
marker, Brn3a, in the 3D-retina differentiated from Fstl4::Venus mouse ESCs, 
indicating specific RGC-subtype differentiation. Second, Venus-positive neurites 
grown from these RGC subsets were positive for beta-III tubulin and SMI312 by 
immunohistochemistry. Enhanced neurite outgrowth was observed in the B27-
supplemented Neurobasal-A medium on Matrigel-coated plates from the optic 
vesicles isolated after 14 days of differentiation from mouse ESCs. For the 
differentiated RGCs from human ESCs, we obtained neurite extension of >4 mm by 
modifying Matrigel coating and the culture medium from the mouse RGC culture. 
Conclusion 
 We successfully optimized the culture conditions to enhance lengthy and high-
frequency neurite outgrowth in mouse and human models. The procedure would be 
useful for not only developmental studies of RGCs, including maintenance and 
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Mammalian retinas are composed of five types of neurons with three 
neuronal layers. Retinal ganglion cells (RGCs) are localized to the layer of the 
vitreous side (ganglion cell layer), and long axons from RCGs extend to various brain 
areas1. As RGCs are the only pathways by which external signals are transmitted 
from the retina to the brain, RGC injury and/or diseases directly lead to visual 
disturbances. The mechanism underlying RGC impairment has been investigated 
using organotypic or dissociated culture systems2. The neurites from RGCs have 
been examined to assess their outgrowth, projections, and maintenance as well as 
molecular responses; this is because these experiments provided essential 
information for developmental, pathological, and physiological studies3,4. However, 
researchers have to consider the species differences underlying morphological and 
developmental characteristics such as RGC subtypes5. In addition, although there 
have been various human RGC disorders6, the ex vivo approaches, particularly 
those with human models, include ethical issues. A few groups have examined 
retinal explant cultures isolated from postmortem adults and reported low viability 
and undetectable neurite outgrowth7-9.  
Recently, to overcome such limitations, several in vitro methods to 
differentiate RGCs from embryoid bodies of mouse or human pluripotent stem cells 
have been proposed10-13. Eiraku et al. reported the development of a retinal serum-
free floating culture of embryoid body-like aggregates with quick reaggregation 
(SFEBq) culture; this provided three-dimensional self-organizing optic vesicle-like 
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structures (3D-retina) with layered retinal neurons14. Each procedure had previously 
confirmed pandifferentiation RGC markers, including Brn3a and/or Brn3b, which are 
responsible for dendritic stratification, maintenance, and projections of RGCs15-17. 
However, because differentiated RGCs are classified into a number of subtypes 
depending on their physiological properties, morphology, central projections, and 
molecular markers5,18-22, these in vitro differentiated RGCs should be characterized 
at the subtype level.  
In this study, we validated the subtype specification of RGCs in the retinal 
SFEBq culture and optimized culture procedures so that neurites of RGCs in the 
optic vesicles would be enhanced and preserved. In the mouse model, we generated 
embryonic stem cells (ESCs) from Follistatin-like 4 (Fstl4)::Venus mice to visualize 
specific subtypes of RGCs and confirm neurite outgrowth. Using optic vesicles 
containing RGCs differentiated from mouse and human ESCs, we optimized each 
culture condition to induce the neurite outgrowth and successfully generated 
numerous and lengthy neurites from RGCs. 
The neurite outgrowth obtained in our optimized culture procedure enables 
quantitative and qualitative analyses of RGCs, making it possible for us to assess 
the pathophysiological and pharmacological studies of mouse and human RGCs by 
minimizing animal sacrifice or purification procedures. 
 
MATERIALS AND METHODS 
Differentiation of 3D-retinas from mouse ESCs 
Fstl4::Venus knock-in mice were obtained from RIKEN BioResource center 
(Tsukuba, Japan)23 and treated in compliance with the Guidelines for Use of 
Laboratory Animals of RIKEN. Fstl4::Venus mouse ESCs were generated as 
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described previously24,25. Mouse ESCs of Fstl4::Venus and Rx::GFP26,27 were 
maintained as reported previously28, and 3D-optic vesicles were differentiated by the 
retinal SFEBq culture protocol14 with minor modifications29. In brief, the embryoid 
bodies forming optic vesicle-like structures around differentiation days (DDs) 7 to 9 
were transferred to floating cultures and maintained. Media were supplemented with 
0.5 µM retinoic acid (RA, Sigma-Aldrich Corp., St. Louis, MO, USA) and 1 mM L-
taurine (Wako Pure Chemical Industries, Osaka, Japan) from DD1430 or after the 
placement of optic vesicles. Undifferentiation (Nanog and Oct4) and differentiation 
(Rx) marker expressions were confirmed by RT-PCR as described previously29 
(primers are listed in Supplemental Table 1). 
 
Differentiation of 3D-retinas from human ESCs 
Rx::Venus and Crx::Venus human ESCs distributed by Dr. Y. Sasai31 were 
used in accordance with human ES cell research guidelines of Japanese 
government. Human ESCs were maintained and differentiated into the 3D-retinas 
as described previously32. In brief, ESCs dissociated by TrypLE Select (Life 
Technologies, Carlsbad, CA, USA) with 0.05 mg/mL DNaseI (Roche Diagnostics, 
Tokyo, Japan) and 20 µM Y-27632 (Wako) were resuspended in the growth factor-
free chemically defined medium (gfCDM), containing IMDM:F12 (1:1, Life 
Technologies), 1× Chemically Defined Lipid Concentrate (Life Technologies), and 
450 µM monothioglycerol (Sigma), supplemented with 10% knockout serum 
replacement (KSR) and 20 µM Y-27632. Twelve thousand cells per well were 
placed into low-cell adhesion V-bottomed 96-well plates (Sumitomo Bakelite, Tokyo, 
Japan). On DD6, the culture medium was changed to gfCDM containing 10% KSR 
and 1.5 nM bone morphogenetic protein 4 (BMP4). Half of the medium was 
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changed every 3 days to gfCDM containing 10% KSR. At DD18, the spheres 
forming optic vesicles were transferred to low-cell adhesion dishes (Sumitomo 
Bakelite) in DMEM/F12 (Life Technologies) containing 1% N2 supplement (Life 
Technologies) and 3 µM CHIR99021(Stemgent, Cambridge, MA, USA). The 
medium was changed at DD22–24 to DMEM/F12 containing 10% fetal bovine 
serum (FBS) (Biological Industries, Beit HaEmek, Israel), 1% N2, 0.5 µM RA, 0.1 
mM L-taurine, and Antibiotic–Antimycotic (Life Technologies) until it was time to 
dissect the optic vesicles. 
 
Neurite outgrowth on adhesion cultures 
The Venus/GFP-positive optic vesicles (DD10–20 in mouse and DD46 in 
human models) excised under a fluorescent dissection microscope (Leica 
Microsystems, Wetzlar, Germany) were placed into 24-well plates or 0.4–1.0-µm 
microporous filter inserts (Corning, Corning, NY, USA) coated with growth factor 
reduced Matrigel (MG-GFR, Corning). For a thicker MG coating, culture vessels 
were covered with 1 µL/cm2 of MG-GFR and solidified at 37°C for 1 h. For a thinner 
MG coating, containers were covered with 1.5–2 µL/cm2 of 10% MG-GFR diluted in 
each substrate media and removed after 1 h of incubation at room temperature. The 
placed optic vesicles were cultured at 37°C in 40% O2 and 5% CO2 in N2-
supplemented DMEM/F12 medium containing either 10% (D-F10), 1% (D-F1), and 
0% (D-F0) of FBS or B27 supplement (D-B27, only for human samples, Life 
Technologies) or in Neurobasal-A medium (Life Technologies) containing B27 
supplement and 1 mM L-glutamine (Sigma) (N-B27). All media were supplemented 
with 0.5 µM RA and 1 mM L-taurine as well as 100 U/mL penicillin and streptomycin 
(Life Technologies). To track neurite outgrowth, spheres were monitored by 
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IncuCyteTM (Essen BioScience, Ann arbor, MI, USA), a time-lapse live-cell imaging 
system built in the incubator that automatically took phase contrast and green 
fluorescent images every 6–8 h. Neurites were counted under an inverted 
microscope DM IL LED (Leica), and pictures were taken using an inverted 
fluorescence microscope IX71 (Olympus, Tokyo, Japan) as required. Culture media 
were changed every 2 days. 
 
Measurement of neurites 
The length of the neurites was measured from the pictures taken by 
IncuCyteTM at 5 days (mouse) or at 4 and 7 days (human) after placement and 
analyzed with ImageJ (1.48v, NIH, Bethesda, MD, USA). The five longest neurites 
from each optic vesicle were chosen and traced from the edge to the end on 
touchscreen displays. After the calculation, the lengths of the three longest neurites 
were statistically evaluated.  
 
Immunohistochemistry and imaging 
Three-dimensional retinal spheres fixed for 30 min in 3% 
paraformaldehyde/phosphate buffered saline (PBS) with 7.5% sucrose were 
cryoprotected in 30 % sucrose/PBS and embedded in O.C.T. compound (Sakura 
Finetek, Tokyo, Japan). Sections (10 µm) were immunostained with primary 
antibodies (Supplemental Table 2). For whole-mount immunostaining, the fixed 3D-
retinas on filter inserts (Corning) were incubated for 2 h in 10% horse serum/PBS 
with 0.5% Triton X-100 (Wako) for blocking at room temperature and for 2 days in 
primary antibodies in 1% horse serum/PBS with 0.05% Triton X-100 at 4°C. 
Secondary antibodies conjugated with Alexa Fluor 488, 546, and 647 were incubated 
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for 1 day at 4°C. The samples were mounted in FluorSaveTM Reagent (Merck 
Millipore, Darmstadt, Germany). All the images for both cryosections and whole-
mount immunohistochemistry samples were obtained from Leica TCS SP8 (Leica). 
 
Statistical analysis 
All data were presented as mean ± standard deviation (S.D.). The numbers and 
length of neurites were analyzed by the Kruskal–Wallis one-way analysis of variance. 
A p value of <0.05 was considered to be statistically significant. If the result showed 
a significant difference, Dunn’s post-hoc comparisons were made between all the 
pairs. Whole statistical analysis was performed using SPSS Statistics (version 
22.0.0.0, IBM, Armonk, NY, USA). 
 
RESULTS 
Neurite outgrowth from Fstl4::Venus mouse ESCs 
To follow neurite outgrowth specifically from RGCs, we generated ESCs from 
Fstl4::Venus-knock-in mice23. Fstl4 (also known as Spig1) has been reported to be 
expressed in two functionally distinct subtypes of RGCs: one was a direction-
selective ON-type RGC, and the other was a lateral geniculate nucleus (LGN)-
projecting RGC localized at the dorsal retina33. After confirming that the Fstl4::Venus 
ESCs exhibited the characteristic morphology and gene expression of pluripotency 
(Figure 1A and B), 3D-retinas were differentiated in our modified SFEBq culture that 
generated optic vesicle, preferentially contacting neural retinas14,29,30. Three-
dimensional retinas examined 10 and 23 days after differentiation (DD10 and DD23) 
expressed Rx, a retinal progenitor marker, while pluripotency-related genes (Nanog 
and Oct4) were downregulated (Figure 1B). As reported previously14,29,30, typical 
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optic vesicle structures with a clear neural epithelium were observed from around 
DD7–10 and gradually enlarged until DD20 (Figure 1D). Rhodopsin-positive cells 
were localized at the inner half of the neural epithelium of optic vesicles at DD20 
(Figure 1C). Venus fluorescence was detectable around DD12 and enhanced by 
DD14 (Figure 1E).  
Following this, we performed morphological and immunohistochemical 
analyses with Brn3a, an RGC marker. At DD10, Brn3a-positive cells were not 
observed but became detectable from DD12 at the outer edge of the optic vesicles, 
corresponding to the spatiotemporal expression in the native mouse retinal 
development34. The expression of Fstl4::Venus was faint at DD12 and enhanced 
from DD14 with non-uniform expression in some of the subpopulation. This finding 
may mimic the expression observed in the native developing retinas33. From DD14 to 
20, we found most Brn3a-positive cells co-expressed Fstl4::Venus (Figure 1F). 
In conventional retinal SFEBq culture, optic vesicles were isolated at DD10 
and placed into low-cell binding dishes in N2-supplemented DMEM/F12 medium with 
10% FBS (D-F10)14. To induce neurite outgrowth from RGCs, we placed them on the 
MG-coated plates (Figure 1G). After 5 days of incubation, Venus-positive neurites 
extended outside optic vesicles (Figure 1H). Math5 and Islet1, transcription factors 
responsible for RGC development, were also positive in the nuclei of neurite-
extending cells (Supplemental Figure 1). 
 
Optimization of culture condition suitable for neurite extension from the 
mouse Fstl4::Venus RGCs 
 To obtain adequate amounts of longer RGC neurites from the optic vesicles 
placed on MG-coated plates, we first optimized the appropriate time points for the 
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placement. The optic vesicles were isolated and placed every 2 or 3 days, and the 
total amount of the neurites was quantified for 5 days after placement (DAP) (Figure 
2A). The optic vesicles placed between DD12 and 17 had more and longer neurites 
than those placed at DD10 and 20 (Figure 2B and C). In DD10 optic vesicles, a small 
number of distinct neurites was observed, while in the DD20 optic vesicle, neurite 
outgrowth was almost undetectable (Figure 2B and C). 
 Following this, we optimized the MG coating and culture medium. The 
isolated optic vesicles were placed on thicker (100%) and thinner (10%) MG-coated 
plates, containing four different culture media with different FBS concentrations and 
supplements that were reported to be suitable for primary RGC cultures (Figure 2D). 
In the case of the thicker MG coating, neurites radially spread in a linear manner in 
the DMEM/F12-based media. However, after extension, an atrophic phenotype with 
thinner neurites was observed in the media with lower FBS concentrations (Figure 
2E); the incidence rates of neurite atrophy per optic vesicles were 60% in D-F10, 
75% in D-F1, 89% in D-F0, and 0% in N-B27 at 5 DAP. The neurite atrophy in the D-
F10 medium suggested that DMEM/F12-based media were not suitable for 
maintaining neurites. On the other hand, optic vesicles cultured in N-B27 showed the 
extension of more neurites without any atrophic phenotype. These neurites radially 
spread, but extended in a winding manner. In the case of the thinner MG coating, 
cells displaying glia-like polygonal morphology (glia-like cells) robustly migrated to 
the outside of the optic vesicles in FBS-containing DMEM/F12-based media (the 
incidence rates at 5 DAP: D-F10 60%, D-F1 88%, D-F0 33%, and N-B27 22%). In 
the N-B27 medium, the neurites formed bundles, and the neighboring bundles 
connected to one another outside the optic vesicles (Figure 2D and 3B).  
 To examine the time course of RGC neuritogenesis, we quantified the 
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number and length of the neurites on the thicker MG-coated series, where no glia-
like cells were observed. In any DMEM/F12-based media (D-F10, D-F1, and D-F0), 
the number of the grown neurites were saturated to approximately 150 per sphere by 
5 DAP (Figure 2F). Neuritogenesis in medium with higher FBS concentrations 
appeared to be delayed. In the N-B27 medium, we observed approximately twice the 
number of neurites than that in DMEM/F12-based media (Figure 2F). For neurite 
length, we measured the three longest neurites in each group because a number of 
neurites in any DMEM/F12-based media showed an atrophic phenotype (Figure 2G). 
Although the neurites in DMEM/F12-based media could reach a length of 
approximately 1 mm, longer neurites in the N-B27 medium were observed. We 
further reconfirmed the appropriate time point of the placement of optic vesicles into 
the N-B27 medium. The optimal time point for placement was DD12–17, which was 
comparable with that for placement for DMEM/F12-based media (Supplemental 
Figure 2). 
 To further examine Venus-positive RGC neurites cultured in the N-B27 
medium, immunohistochemical analyses were performed with antibodies for beta-III 
tubulin, a neuron-specific cytoskeletal protein, and SMI312, a pan-axonal 
neurofilament marker (Figure 3A and B). Colocalization of beta-III tubulin and 
SMI312 in neurites was observed, indicating that all neurites outside the optic 
vesicles showed axonal characteristics. In the case of the thicker MG coating, the 
Venus protein visualized a partial fraction of the outgrown neurites, verifying that 





Optimization of culture condition suitable for neurite extension of RGCs 
differentiated from the human ESCs 
To further expand the human RGC studies, we optimized the culture 
procedure suitable for RGCs differentiated from human ESCs. We first performed 
section immunohistochemistry with pan-RGC markers (BRN3A and BRN3B) of 
approximately DD46 3D-retinas differentiated by the modified human retinal SFEBq 
culture procedure32 (Figure 4A–C). We confirmed that these marker expressions 
were comparable with those in previously reported methods31.  
Following this, we optimized the culture procedure by placing the DD46 optic 
vesicles on either thinner or thicker MG-coated plates in various culture media. First, 
we tested culture media containing FBS (D-F10, D-F1, and D-F0). As observed in 
the mouse RGC culture, the neurites showed atrophic phenotypes in the case of the 
thicker MG coating (Figure 4D upper panels and E; the incidence rates at 7 DAP: D-
F10 29%, D-F1 57%, D-F0 100%, D-B27 29%, and N-B27 14%). The glia-like cells 
were detected on the thinner MG coating (the incidence rates at 7 DAP: D-F10 100%, 
D-F1 100%, D-F0 17%, D-B27 17%, and N-B27 0%), although neurites were visible 
in comparison with those of the mouse RGCs (Figure 4D lower left and middle 
panels). We then examined B27-supplemented media. In the case of the thicker MG 
coating, neurite outgrowth and maintenance were improved in the D-B27 and N-B27 
(Figure 4F, upper panels). These neurites formed bundles; however, they radially 
spread linearly with less connection to the neighboring bundles. On the thinner MG 
coating, longer neurites extended further than those on the thicker MG coating, 
forming bundles that linearly spread and were connected to each other (Figure 4F, 
lower panels). In the D-B27 medium, up to 4 mm of bundled neurites were observed 
(Figure 4F and G).  
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 Furthermore, we estimated neuritogenesis in number and length. The B27-
supplemented media (D-B27 and N-B27) caused a significant increase in the 
number of outgrown neurites at 4.5 and 7 DAP (Figure 4H). The length of the three 
longest neurites in each group on both the thicker and thinner MG coating (Figure 4I 
and J) indicated that longer neurites could be particularly observed in B27-
supplemented media. This finding strongly suggested that the B27 supplement is 
required for human RGC neuritogenesis and maintenance. 
 Using whole-mount fluorescent immunohistochemistry, the neurites from 
placed optic vesicles were double-labeled with beta-III tubulin and SMI312 (Figure 5). 
In the D-F10 medium with the thicker MG coating, immunostained signals were 
preferentially detected on the surface of the optic vesicles, while the neurites 
cultured in any B27-supplemented media grew outside the vesicles. In the D-F10 
medium with the thinner MG coating, the neurites traversed the glia-like cells that 
had migrated outside the vesicles (Figure 5, lower left panel). 
 
DISCUSSION 
When in vitro differentiated RGCs are studied, it is important to (1) verify 
differentiation status of RGCs and (2) clearly visualize and maintain the neurite 
outgrowth. Organotypic cultures by isolating living animals are more advantageous 
than dissociated single-cell culture because the tissue environment such as 
differentiated cell types, retinal neurons, intercellular connectivity, and extracellular 
components is retained35. However, because these procedures require living animals 
at each developmental time point of interest, it was not practical to use this type of 
model for precise developmental analyses such as embryonic RGC studies. We 
would face difficulties with this type of testing in human models. Recently, several 
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methods to differentiate RGCs from embryoid bodies of mouse or human pluripotent 
stem cells have been proposed and have confirmed the expression of Brn3, a 
differentiation marker of RGCs10-13. The modified retinal SFEBq culture provided 3D-
retinas with laminated retinal neurons14,29. In this study, we observed Fstl4-
expressing RGCs in the 3D-retinas, strongly indicating that RGCs in the optic 
vesicles are differentiated at the subtype level. Thus, our 3D-retinas would be ideal 
for RGC studies. 
In our 3D-retinas, co-expressions of Brn3a and Fstl4::Venus were observed.  
However, considering that both Brn3a and Fstl4 are expressed in the subpopulation 
of RGCs15,33, a concern remains regarding the possible existence of non-RGC 
neurites without Venus- nor Brn3a-expression, although both Venus-positive and -
negative neurites indicated similar morphology. To reduce this possibility, we isolated 
optic vesicles with strong Venus fluorescence. These would correspond to the 
dorsotemporal region of the native mouse retinas where Fstl4-positive RGCs are 
densely distributed33. Thus, in this study, almost all of the neurites were Fstl4::Venus-
positive. 
 To visualize and maintain the neurite outgrowth from the 3D-retinas, we 
manipulated the timing of the excision and placement, culture media, and biological 
coating. The most suitable combinations in mouse and human models are listed in 
Table 1. 
The timing of placement has been considered in organotypic culture of 
mouse RGCs. To grow many neurites from RGCs, it was common that retinal tissues 
were dissected in the last embryonic week36-38. This trend was reproducible in the 
3D-retinas. Placement from DD12 to DD17 resulted in good neuritogenesis, which is 
consistent with the developmental window of the native mouse RGCs39. The optic 
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vesicles isolated at DD20 showed lesser and shorter neuritogenesis. Considering 
that RGCs at DD20 are localized at the outer edge of optic vesicles, they would be 
damaged before placement. In the human retina, RGC development begins from 
postconceptional day (PCD) 38 and peaks at PCD 5240; therefore, it would be 
reasonable to place the human optic vesicles at DD46. 
In the medium selection after placement, we tested the maturation media 
used in the conventional 3D-retinal differentiation protocol14 (D-F10 and D-F0) as 
well as the media preferentially used in the mouse explant culture4,38 (N-B27 and D-
B27). In the media of D-F1 as well as in D-F10 and D-F0, neuritogenesis was 
observed; however, atrophic phenotype or glia-like cells emerged depending on the 
MG coating within 5 DAP. On the other hand, N-B27 and D-B27 media preserved the 
outgrown neurites without the proliferation of glia-like cells; this suggests that the 
B27 supplement, commonly used for retinal explant culture, is suitable for RGC 
culture. FBS would not be sufficient to maintain the grown neurites but would 
promote glial proliferation similar to glial cells in primary retinal and central nervous 
system neuronal cultures38,41. In the human model, Neurobasal-A as well as 
DMEM/F12/N2 was acceptable. 
In the biological coating, poly-D-lysine, collagen, laminin, and Matrigel have 
been selected to promote and preserve the neuritogenesis of RGCs from retinal 
explants3,4,42-44. In our optimization, we focused on Matrigel because biological 
coating with a single molecule insufficiently promoted neurite outgrowth (data not 
shown). Our results showed significant neurite outgrowth in both mouse and human 
models. Matrigel is composed of laminin, collagen type IV, entactin, and heparan 
sulfate proteoglycan (HSPG) and contains bFGF, NGF, and TGF beta. Laminin is 
known as a major component of the inner limiting membrane of the retina45, and was 
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reported to promote neurite outgrowth of the retinal explants46. Considering that 
HSPG is restricted to the inner surface of the developing mouse retina47, and that 
HSPG-supported bFGF signaling regulates axonal pathfinding during RGC 
development48,49, HSPG in Matrigel would play a role in expanding neurites outside 
the optic vesicles. The optic vesicles in the 3D-retinas, which are floating on the 
culture medium and do not have vitreum, would have less laminin and/or HSPG on 
the surface of the RGC layer. This could be attributed to better neuritogenesis 
because of Matrigel in the 3D-retinas. 
We optimized culture systems to assess the neurite outgrowth of RGCs from 
3D-retina-like tissues differentiated from mouse and human ESCs without the 
purification process. These culture conditions require further modifications 
depending on the purpose. However, the present method may provide quantitative 
evaluation of RGC-neurite viability, outgrowth, and projections, which are suitable for 
pathophysiological and pharmacological studies also applicable to human RGCs. 
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Figure 1. Three-dimensional retina differentiation and neurite outgrowth of 
optic vesicles differentiated from Fstl4::Venus mouse ESCs 
(A) Phase-contrast micrograph of feeder-free culture of Fstl4::Venus-knock-in mouse 
ESCs. Scale bar: 100 µm. 
(B) RT-PCR detected the expression of Nanog, Oct4, Rx, and G3pdh (endogenous 
control) before differentiation and at differentiation day (DD) 10 and DD23 from 
Fstl4::Venus mouse ESCs. 
(C) Section immunohistochemistry of the DD20 optic vesicle differentiated from 
Fstl4::Venus mouse ESCs, stained with the Rhodopsin (red) antibody and DAPI 
(blue). Scale bar: 50 µm. 
(D–E) Developmental images of the 3D-retinas from the Fstl4::Venus ESCs. Optical 
(D) and fluorescence (E) micrographs of the 3D-retinas from DD10 to DD20 were 
shown. Scale bar: 200 µm. 
(F) Venus (green) and Brn3a (red) fluorescence during 3D-retina differentiation, as 
shown in confocal microscopic images of immunohistochemistry in optic vesicles 
between DD10 and DD20, counter-stained with DAPI (blue) for nuclei. Magnified 
views of the area surrounded by white squares were located under the left-lower 
of former images at DD12 to DD20. Scale bar: 50 µm in main images and 10µm 
in magnified images. 
(G) The schematic diagram of the procedure for 3D-retina differentiation from mouse 
ESCs and neurite outgrowth. SFEBq; serum-free floating culture of embryoid 
body-like aggregates with quick reaggregation, KSR; knockout serum 
replacement, AGN; retinoic acid receptor antagonist AGN193109, GFR; growth 
factor reduced, RA; retinoic acid. 
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(H) Phase-contrast and fluorescent images of Venus-positive neurites from optic 
vesicles of differentiated 3D-retina obtained by IncuCyte (upper) and Olympus 
IX71 (lower). The white square represents the area of the lower panels. Scale 
bar: 500 µm. 
 
Figure 2. Optimization of culture conditions for neurite extension from the 
mouse Fstl4::Venus RGCs 
(A) Line chart of the mean number of the neurites extended in N2-supplemented 
DMEM/F12 medium with FBS10% (D-F10) on 100% (thicker) Matrigel (MG)-coated 
plates, depending on the initial differentiation day (DD).  
(B) Bar graph indicating the mean number of the neurites extended at 3 days after 
placement (DAP) (left group) and 5 DAP (right group) in D-F10 medium on 100% 
(thicker) MG-coated plates. 
(C) Bar graph of the mean length of three longest neurites at 5 DAP. Longer neurites 
extended at 5 DAP from DD12 to DD17. *p < 0.05. 
(A–C) Values were presented as means ± standard deviation (S.D.). (DD10 n = 6, 
DD12 n = 5, DD14 n = 10, DD17 n = 6, DD20 n = 5). 
(D) Phase-contrast micrographs of the neurites at 5 DAP in N2-supplemented 
DMEM/F12 medium with 10% (D-F10), 1% (D-F1), and 0% (D-F0) FBS or B27 
supplemented Naurobasal-A medium (N-B27) placed on 100% (upper panels) or 
10% (lower panels) MG-coated plates. Scale bar: 200 µm. 
(E) Phase-contrast micrograph showing neuritric atrophy of the 2-DAP optic vesicle 
in D-F0 medium. Scale bar: 200 µm. 
(F) The bar graph of the mean number of the neurites extended at 1, 3, and 5 DAP in 
various media on 100% (thicker) MG-coated plates. 
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(G) The bar graph of the mean length of three longest neurites per sphere at 5 DAP 
in various media on 100% (thicker) MG-coated plates. 
(F–G) Values were presented as means ± S.D. (*p < 0.05, **p < 0.01. D-F10 n = 10, 
D-F1 n = 8, D-F0 n = 9, N-B27 n = 9). 
 
Figure 3. Whole-mount immunohistochemistry of the neurites from the 
Fstl4::Venus optic vesicles 
(A–B) The Maximum intensity projection images of whole-mount 
immunohistochemistry of neurites extended on thicker (A) or thinner (B) MG-coated 
inserts cultured in the N-B27 medium. The neurites were visualized by Venus (green), 
beta-III tubulin (red), and SMI312 (cyan). Lower panels indicate the higher 
magnification images of the areas framed by white squares in the upper panel. Scale 
bar: 500 µm (upper), 200 µm (lower).  
 
Figure 4. Optimization of culture conditions suitable for neurite extension from 
the human Crx::Venus RGCs 
(A) Phase-contrast (upper) and fluorescence (lower) micrographs of 3D-retina-like 
spheres derived from Rx::Venus (left) and Crx::Venus (right) human ESCs. Scale 
bar: 200µm. 
(B) Confocal microscopic image of section immunohistochemistry of DD45 optic 
vesicles differentiated from Rx::venus human ESCs, costained with DAPI (blue), 
Brn3b (left panel, red), or Brn3a (right panel, red) as RGC markers. Scale bar: 50 µm. 
(C) The schematic diagram of the procedure for 3D-retina differentiation from the 
human ESCs and the neurites outgrowth. gfCDM; growth factor-free chemically 
defined medium, BMP4; bone morphogenetic protein 4, GSK3i; glycogen synthase 
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kinase 3 inhibitor. 
(D–F) Phase-contrast micrographs of the grown neurites. Scale bar: 200 µm. 
(D) Neurites extended at 7 DAP cultured in D-F10, D-F1, and D-F0 media placed on 
100% (upper) or 10% (lower) MG-coated plates. 
(E) Phase-contrast micrograph showing neuritric atrophy (white arrowhead) of the 
neurites at 1.5 (upper) and 3 (lower) DAP in the D-F0 medium with 100% MG 
coating. 
(F) Neurites extended at 7 DAP cultured in D-B27 and N-B27 media. 
(G) Diagram tracing neurites observed at 7 DAP in the D-B27 medium with 10% MG 
coating. A number of neurites longer than 4 mm were observed. Scale bar: 2 mm. 
(H) The bar graph of the mean number of the neurites extended at 1.5 (left), 4.5 
(middle), and 7 (right) DAP in the different media. 
(I) The bar graph of the mean length of three longest neurites per sphere at 7 DAP 
with 100% MG coating. 
(J) The bar graph of the mean length of three longest neurites per sphere at 7 DAP 
with 10% MG coating. 
(H–J) Values were presented as means ± S.D. (*p < 0.05, **p < 0.01. 100% MG n = 
7, 10% MG n = 6 for each group) 
 
Figure 5. Whole-mount immunohistochemistry of the neurites from the 
Crx::Venus optic vesicles 
The maximum intensity projection images of whole-mount immunohistochemistry of 
neurites extended on thicker (upper) or thinner (lower) MG-coated inserts cultured in 
the D-F10 (left), D-B27 (middle), and N-B27 (right) media. The images of the 
neurites and optic vesicles visualized by beta-III tubulin (red), SMI312 (green), and 
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Crx::Venus (white) were merged with the images stained with DAPI (blue). Scale bar: 
200 µm. 
 
 
 
 
 







